RIGEL PHARMACEUTICALS INC Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Rigel Pharmaceuticals Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Rigel Pharmaceuticals Inc Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $405K, a 59.8% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $405K -$603K -59.8% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $560K -$437K -43.8% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $712K -$411K -36.6% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $861K -$1.07M -55.4% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $1.01M -$1.98M -66.3% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $997K -$4.25M -81% Jun 30, 2023 10-Q 2023-08-01
Q1 2023 $1.12M -$6.41M -85.1% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 $1.93M -$7.77M -80.1% Dec 31, 2022 10-K 2024-03-05
Q3 2022 $2.99M -$8.83M -74.7% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $5.25M -$8.65M -62.3% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $7.53M -$8.39M -52.7% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 $9.7M -$8.19M -45.8% Dec 31, 2021 10-K 2023-03-07
Q3 2021 $11.8M -$8.05M -40.5% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $13.9M -$8.02M -36.6% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 $15.9M -$7.86M -33% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $17.9M -$7.81M -30.4% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $19.9M -$7.77M -28.1% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $21.9M -$7.5M -25.5% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 $23.8M -$7.36M -23.6% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 $25.7M Dec 31, 2019 10-K 2021-03-02
Q3 2019 $27.6M Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $29.4M Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $31.1M Mar 31, 2019 10-Q 2019-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.